Research Report 2009

CIKA vice-president, Ellen Webb, produced the following image for fund-raising presentations. If you would like a representative of CIKA to make a presentation to your club or society on behalf of CIKA, email Ellen by clicking here.

Findings to date:
no adverse effects from dendritic cell vaccination;
objective clinical responses in five of the treated patients.

To date the trial has achieved the following results:

Disease indication	Patients enrolled	Patients completed vaccines
Newly diagnosed stage 4 neuroblastoma	15	5
Recurrent solid tumours	4	2
Recurrent solid tumours	5	1